The method for treating CEA positive cancers using PD-1 axis binding antagonists and anti-CEA/ AntiCD3 McAbs bispecific antibody

• 收藏
• 分享

专利权人:

F. HOFFMANN-LA ROCHE AG

发明人:

CHRISTIAN KLEIN,JOHANNES SAM,JOSE SARO,MARINA BACAC,PABLO UMAÑA,SARA COLOMBETTI

申请号：

BR112018011029

公开号：

BR112018011029A2

申请日:

2017.01.05

申请国别(地区):

BR

年份:

2018

代理人:

摘要：

The present invention is provided to treat the composition of CEA positive cancers and method.This method includes the bispecific antibody applied 1 axis binding antagonists of PD and target CEA and CD3.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/